In vitro and in vivo evaluation of the main protease inhibitor FB2001 against SARS-CoV-2
Weijuan Shang, Wenhao Dai, Cheng Yao, Ling Xu, Xiangming Tao, Haixia Su, Jian Li, Xiong Xie, Yechun Xu, Min Hu, Dong Xie, Hualiang Jiang, Leike Zhang, Hong Liu
Topics & Concepts
In vivoVero cellIn vitroEC50Ex vivoPharmacologyChemistryIC50Protease inhibitor (pharmacology)TiterMolecular biologyVirologyBiologyVirusViral loadBiochemistryAntiretroviral therapyBiotechnologySARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesComputational Drug Discovery Methods